The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

May. 14, 2017
Applicant:

Ossianix, Inc., Philadelphia, PA (US);

Inventors:

Julien Häsler, Hitchin, GB;

Julia Lynn Rutkowski, Bryn Mawr, PA (US);

Krzysztof Bartlomiej Wicher, Cambridge, GB;

Assignee:

Ossianix, Inc., Philadelphia, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); C07K 16/40 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C12N 15/85 (2006.01); A61K 39/00 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
A61K 39/395 (2013.01); C07K 16/2881 (2013.01); C07K 16/40 (2013.01); C07K 16/464 (2013.01); C12N 15/85 (2013.01); A61K 2039/505 (2013.01); C07K 2317/20 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/32 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/35 (2013.01); C07K 2317/52 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/64 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2318/10 (2013.01); G01N 33/53 (2013.01);
Abstract

The present invention relates to peptides that bind with high specificity and which functionally interact with the transferrin receptor ('TfR') and which may be used in making molecular vehicles that carry biomolecules across membranes, including, e.g., across the blood brain barrier or the gastrointestinal tract. TfR specific binding moieties may also be used alone or as components in specific molecules that target the transferrin/transferrin receptor transport system. The invention relates more specifically to VNAR single chain antibodies derived from nurse shark that bind to TfR, compounds and compositions comprising a TfR specific VNAR binding moiety, methods for preparing them, diagnostic and therapeutic methods of use in vitro or in vivo, e.g., to diagnose, treat and/or prevent a pathological condition, disorder or disease in which it is beneficial to deliver a heterologous biomolecule across the blood brain barrier by association with a TfR specific VNAR binding moiety. Other uses for TfR specific VNAR binding moieties of the invention include, e.g., regulating the interaction of iron-charged transferrin with TfR (receptor cycling or cell surface presentation), such as may be therapeutic in treatment of certain cancer cells and tumors of various tissue types.


Find Patent Forward Citations

Loading…